5Gravalos C.Ma,rquez A, Garcra-Carbonero R. et al. Correlation between Her-2/neu overexpression/amplifieation and clinieopathological pa- rameters in advanced gastric cancer Patients: a prospective study[c]. Gastrointestinal CancersSymposium, 2007,130:Abstr 89.
6Osoba D, Simon D J, Burchmore M, et al. Effects on quality of life of combined trastuzumab and chemotherapy in women with metastatic breast cancer[J]. J Oin Oncol, 2002,20(14):3106-3113.
7Rebischung C, Barnoud R, Stefani L, et al. The effectiveness of trastuzumab (Herceptin) combined with chemotherapy for gastric car- cinoma with overexpression of the c-erbB-2 protein [J]. Gastric Can- cer,2005,(8):249.
8Fujimoto-Ouehi K, Sekiguchi F, Yasuno H. Antitumor activity of trastuzumab in combination with chemotherapy in human gastric cancer xenograft models [J]. Cancer Chemother Pharmaeol, 2007,59 (6): 795-805.
9Osoba D, Simon DJ, Burchmore M, et al. Effects on quality of life of combined trastuzumab and chemotherapy in women with metastatic breast cancer[J]. JOin Oncol, 2002,20( 14):3106-3113.
10Yu W, Whang I, Chung HY, Averbach A, Sug- arbaker PH. Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial. World J Surg 2001; 25:985-990 [PMID: 11571980 DOI: 10.1007/s00268-001-0067-7].
